Latest Legal News

NEWS & INVESTIGATIONS

Women with Ovarian Cancer Sue Johnson & Johnson Over Talcum Power

Attorneys are now filing lawsuits in New Jersey and Missouri alleging that the talc in Johnson & Johnson’s body powder has caused ovarian cancer in women and the company failed to warn them about this risk. Around 700 lawsuits have now been filed, according to media reports.

Women with Ovarian Cancer Sue Johnson & Johnson Over Talcum Power

Lawsuits Filed Over Johnson & Johnson Talc and Ovarian Cancer

Products Involved in the Allegations

The product is normally referred to as baby powder but it is also sold by Johnson & Johnson under the name Shower to Shower as part of its body powder products. The lawsuits allege that regular application of the product to the genital region increases the risk of cancer.

Prevalence and Impact of Ovarian Cancer

One out of 70 women are diagnosed with this form of cancer and around 14,000 die annually from it. It is the fifth leading cause of cancer-related deaths among women.

Scientific Research Linking Talc to Ovarian Cancer

Some researchers estimate that there may be as many as 2,100 cases of the diagnosed ovarian cancer annually in the U.S. causally linked to talcum powder use. Studies suggesting a link between talc use and ovarian cancer date back to the 1980s with research starting in the 1970s on this issue. They estimate that the risk of ovarian cancer through regular talcum powder use increases by about 35 percent. If you or a loved one was affected, contact us today to learn more about your rights.

Related Articles

Bristol Township – Two Injured by Space Heater

Two Bristol Township residents suffered significant burns and were airlifted to Temple Hospital after an electric space heater started a fire that caused significant damage to their home. Fire department officials arrived around 4:00 a.m. and stated that no smoke…

Boppy Newborn Lounger and Infant Pillow Recall

Boppy Newborn Lounger and Infant Pillow Recalls Exhausted parents and caregivers are constantly on the lookout for any device or product that can help them to care for their newborns. While some popular infant loungers include warnings against allowing newborns…

Momaid Infant Lounger CPSC Warning

On June 8, 2023, the US Consumer Product Safety Commission (CPSC) issued a warning about the Momaid infant lounger. According to that warning, the product does not meet critical US safety standards for infant sleep products.  Danger Presented by the…

Weight-Loss Drug Vision Loss Lawsuits (Ozempic®, Wegovy®, Mounjaro®, Zepbound®): What Patients Need to Know

GLP-1 medications like Ozempic® and Wegovy® (semaglutide) and Mounjaro® and Zepbound® (tirzepatide) have transformed the treatment of diabetes and obesity. For many patients, these drugs are life-changing. At the same time, a growing number of patients have reported sudden, sometimes…